STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc reports the purchase and cancellation of 354,000 ordinary shares of  each under the second tranche of its share buyback programme announced 31 July 2025. Following settlement, registered share capital is 8,955,967,411 ordinary shares, of which 3,880,205 are held as treasury shares, leaving 8,952,087,206 ordinary shares with voting rights. The announcement notes the trade venue (London Stock Exchange CBOE (UK)/CXE) and provides a link to a full breakdown of individual trades. The company also states this is not an offer for securities and that details are available on its investor website.

Haleon plc comunica l'acquisto e la cancellazione di 354.000 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto azionario annunciato il 31 luglio 2025. Dopo il regolamento, il capitale sociale registrato ammonta a 8.955.967.411 azioni ordinarie, di cui 3.880.205 detenute come azioni proprie in portafoglio, lasciando 8.952.087.206 azioni ordinarie con diritto di voto. L'annuncio indica la sede di negoziazione (London Stock Exchange CBOE (UK)/CXE) e fornisce un collegamento alla ripartizione completa delle singole operazioni. La società precisa inoltre che non si tratta di un'offerta di titoli e che i dettagli sono disponibili sul sito per gli investitori.

Haleon plc informa sobre la compra y cancelación de 354.000 acciones ordinarias en la segunda fase de su programa de recompra de acciones anunciado el 31 de julio de 2025. Tras la liquidación, el capital social registrado es de 8.955.967.411 acciones ordinarias, de las cuales 3.880.205 se mantienen como acciones en tesorería, quedando 8.952.087.206 acciones ordinarias con derecho a voto. El comunicado señala el mercado de negociación (London Stock Exchange CBOE (UK)/CXE) y ofrece un enlace con el desglose completo de las operaciones individuales. La compañía también aclara que no se trata de una oferta de valores y que los detalles están disponibles en su web para inversores.

Haleon plc는 2025년 7월 31일 발표한 자사주 매입 프로그램의 두 번째 분할(tranche)에서 보통주 354,000주를 매입·소각했다고 보고합니다. 정산 후 등록 자본은 8,955,967,411 보통주이며, 이 중 3,880,205주는 자사주로 보유되어 투표권이 있는 보통주는 총 8,952,087,206주입니다. 공고에는 거래 장소(London Stock Exchange CBOE (UK)/CXE)가 명시되어 있고, 개별 거래 내역의 전체 분해 링크가 제공됩니다. 회사는 또한 이것이 증권에 대한 제안이 아니며 세부 정보는 투자자 웹사이트에서 확인할 수 있다고 밝혔습니다.

Haleon plc annonce l'achat et l'annulation de 354 000 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat d'actions annoncé le 31 juillet 2025. Après règlement, le capital social enregistré s'élève à 8 955 967 411 actions ordinaires, dont 3 880 205 sont détenues en actions propres, laissant 8 952 087 206 actions ordinaires avec droit de vote. L'annonce précise le lieu de négociation (London Stock Exchange CBOE (UK)/CXE) et fournit un lien vers la ventilation complète des transactions individuelles. La société indique également qu'il ne s'agit pas d'une offre de titres et que les détails sont disponibles sur son site investisseurs.

Haleon plc meldet den Erwerb und die Vernichtung von 354.000 Stammaktien im Rahmen der zweiten Tranche seines am 31. Juli 2025 angekündigten Aktienrückkaufprogramms. Nach der Abwicklung beträgt das eingetragene Grundkapital 8.955.967.411 Stammaktien, davon werden 3.880.205 als eigene Aktien gehalten, sodass 8.952.087.206 stimmberechtigte Stammaktien verbleiben. Die Bekanntmachung nennt den Handelsplatz (London Stock Exchange CBOE (UK)/CXE) und enthält einen Link zur vollständigen Aufschlüsselung der Einzeltransaktionen. Das Unternehmen stellt außerdem klar, dass es sich nicht um ein Angebot von Wertpapieren handelt und dass Einzelheiten auf seiner Investoren-Website verfügbar sind.

Positive
  • Buyback executed: Company completed purchase and cancellation of 354,000 ordinary shares under its announced programme.
  • Updated capital figures: Provides precise post-transaction counts: 8,955,967,411 registered shares; 3,880,205 treasury shares; 8,952,087,206 voting shares.
  • Regulatory transparency: Includes trade venue and link to full individual trade breakdown complying with Market Abuse Regulation disclosure requirements.
Negative
  • None.

Insights

TL;DR: Small executed share buyback slightly reduces shares outstanding and provides updated voting share count.

The report documents a completed purchase and cancellation of 354,000 ordinary shares under the previously announced buyback programme. This reduces the company's registered shares and adjusts the number of voting shares to 8,952,087,206, a useful operational figure for disclosure thresholds under UK rules. The disclosure includes venue and a link to the trade breakdown, meeting market transparency requirements. The transaction size is modest relative to total shares outstanding and is a routine capital-return activity rather than a material corporate event.

TL;DR: Proper regulatory disclosure of buyback execution and updated voting share count; no governance red flags apparent.

The Form 6-K supplies the required market abuse regulation trade breakdown link and confirms cancellation of shares, which affects the company's issued capital and treasury holdings. The announcement clarifies the voting-share figure that shareholders must use for disclosure obligations. There is no indication of executive changes, litigation, or other governance actions in this notice; it reads as compliant, routine disclosure.

Haleon plc comunica l'acquisto e la cancellazione di 354.000 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto azionario annunciato il 31 luglio 2025. Dopo il regolamento, il capitale sociale registrato ammonta a 8.955.967.411 azioni ordinarie, di cui 3.880.205 detenute come azioni proprie in portafoglio, lasciando 8.952.087.206 azioni ordinarie con diritto di voto. L'annuncio indica la sede di negoziazione (London Stock Exchange CBOE (UK)/CXE) e fornisce un collegamento alla ripartizione completa delle singole operazioni. La società precisa inoltre che non si tratta di un'offerta di titoli e che i dettagli sono disponibili sul sito per gli investitori.

Haleon plc informa sobre la compra y cancelación de 354.000 acciones ordinarias en la segunda fase de su programa de recompra de acciones anunciado el 31 de julio de 2025. Tras la liquidación, el capital social registrado es de 8.955.967.411 acciones ordinarias, de las cuales 3.880.205 se mantienen como acciones en tesorería, quedando 8.952.087.206 acciones ordinarias con derecho a voto. El comunicado señala el mercado de negociación (London Stock Exchange CBOE (UK)/CXE) y ofrece un enlace con el desglose completo de las operaciones individuales. La compañía también aclara que no se trata de una oferta de valores y que los detalles están disponibles en su web para inversores.

Haleon plc는 2025년 7월 31일 발표한 자사주 매입 프로그램의 두 번째 분할(tranche)에서 보통주 354,000주를 매입·소각했다고 보고합니다. 정산 후 등록 자본은 8,955,967,411 보통주이며, 이 중 3,880,205주는 자사주로 보유되어 투표권이 있는 보통주는 총 8,952,087,206주입니다. 공고에는 거래 장소(London Stock Exchange CBOE (UK)/CXE)가 명시되어 있고, 개별 거래 내역의 전체 분해 링크가 제공됩니다. 회사는 또한 이것이 증권에 대한 제안이 아니며 세부 정보는 투자자 웹사이트에서 확인할 수 있다고 밝혔습니다.

Haleon plc annonce l'achat et l'annulation de 354 000 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat d'actions annoncé le 31 juillet 2025. Après règlement, le capital social enregistré s'élève à 8 955 967 411 actions ordinaires, dont 3 880 205 sont détenues en actions propres, laissant 8 952 087 206 actions ordinaires avec droit de vote. L'annonce précise le lieu de négociation (London Stock Exchange CBOE (UK)/CXE) et fournit un lien vers la ventilation complète des transactions individuelles. La société indique également qu'il ne s'agit pas d'une offre de titres et que les détails sont disponibles sur son site investisseurs.

Haleon plc meldet den Erwerb und die Vernichtung von 354.000 Stammaktien im Rahmen der zweiten Tranche seines am 31. Juli 2025 angekündigten Aktienrückkaufprogramms. Nach der Abwicklung beträgt das eingetragene Grundkapital 8.955.967.411 Stammaktien, davon werden 3.880.205 als eigene Aktien gehalten, sodass 8.952.087.206 stimmberechtigte Stammaktien verbleiben. Die Bekanntmachung nennt den Handelsplatz (London Stock Exchange CBOE (UK)/CXE) und enthält einen Link zur vollständigen Aufschlüsselung der Einzeltransaktionen. Das Unternehmen stellt außerdem klar, dass es sich nicht um ein Angebot von Wertpapieren handelt und dass Einzelheiten auf seiner Investoren-Website verfügbar sind.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
04 September 2025 - “Transaction in Own Shares”
 
 
 
 
99.1
 
Haleon plc: Transaction in own shares
 
04 September 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 354,000 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
03 September 2025
03 September 2025
03 September 2025
Number of Shares purchased:
354,000
-
-
Highest price paid per Share (p):
370.3000
-
-
Lowest price paid per Share (p):
363.4000
-
-
Volume weighted average price paid per Share (p):
366.1277
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,955,967,411 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,952,087,206 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/9239X_1-2025-9-3.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 04, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

What share buyback did Haleon (HLN) report on 04 September 2025?

Haleon reported the purchase and cancellation of 354,000 ordinary shares under the second tranche of its buyback programme.

How many Haleon shares are outstanding with voting rights after the transaction?

After settlement the number of ordinary shares with voting rights is 8,952,087,206.

Where can I find the detailed breakdown of the individual trades?

The announcement provides a link to the trade breakdown at http://www.rns-pdf.londonstockexchange.com/rns/9239X_1-2025-9-3.pdf and on Haleon's investor website.

Does this announcement constitute an offer for securities?

No. The announcement explicitly states it does not constitute, or form part of, an offer or solicitation of an offer for securities.

How many treasury shares does Haleon hold after this transaction?

The company holds 3,880,205 treasury shares following the settlement.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

44.04B
4.48B
0.02%
12.82%
0.39%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge